共 180 条
- [1] Abel E.L., Marihuana and memory: acquisition or retrieval?, Science, 73, pp. 1038-1040, (1971)
- [2] Abuhasira R., Schleider L.B., Mechoulam R., Novack V., Epidemiological characteristics, safety and effi cacy of medical cannabis in the elderly, Eur. J. Intern. Med., 49, pp. 44-50, (2018)
- [3] Abush H., Akirav I., Cannabinoids modulate hippocampal memory and plasticity, Hippocampus, 20, pp. 1126-1138, (2010)
- [4] Abush H., Akirav I., Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats, PLoS One, 7, pp. 3171-3173, (2012)
- [5] Alexander S.P., Therapeutic potential of cannabis-related drugs, Prog. Neuropsychopharmacol. Biol. Psychiatry, 64, pp. 157-166, (2016)
- [6] Altamura C., Ventriglia M., Martini M.G., Et al., Elevation of plasma 2-arachidonoylglycerol levels in Alzheimer’s disease patients as a potential protective mechanism against neurodegenerative decline, J. Alzheimers Dis., 46, pp. 497-506, (2015)
- [7] Andrade-Talavera Y., Duque-Feria P., Paulsen O., RodriguezMoreno A., Presynaptic spike timing-dependent long-term depression in the mouse hippocampus, Cereb. Cortex, 26, 8, pp. 3637-3654, (2016)
- [8] Anokhin K.V., Tiunova A.A., Rose S.P., Reminder effects – reconsolidation or retrieval deficit? Pharmacological dissection with protein synthesis inhibitors following reminder for a passive-avoidance task in young chicks, Eur. J. Neurosci., 15, pp. 1759-1765, (2002)
- [9] Aso E., Ferrer I., Cannabinoids for treatment of Alzheimer’s disease: Moving toward the clinic, Front. Pharmacol., 5, (2014)
- [10] Aso E., Juvis S., Maldonado R., Ferrer I., CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice, J. Alzheimers Dis., 35, pp. 847-858, (2013)